Literature DB >> 11071652

Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria.

D Genini1, S Adachi, Q Chao, D W Rose, C J Carrera, H B Cottam, D A Carson, L M Leoni.   

Abstract

Adenine deoxynucleosides induce apoptosis in quiescent lymphocytes and are thus useful drugs for the treatment of indolent lymphoproliferative diseases. To explain why deoxyadenosine and its analogs are toxic to a cell that is not undergoing replicative DNA synthesis, several mechanisms have been proposed, including the direct binding of dATP to the pro-apoptotic factor Apaf-1 and the activation of the caspase-9 and -3 pathways. In this study it is shown, by means of several assays on whole cells and isolated mitochondria, that 2-chloro-2'-deoxyadenosine (2CdA) and 2-choloro-2'-ara-fluorodeoxyadenosine (CaFdA) disrupt the integrity of mitochondria from primary chronic lymphocytic leukemia (B-CLL) cells. The nucleoside-induced damage leads to the release of the pro-apoptotic mitochondrial proteins cytochrome c and apoptosis-inducing factor. The other adenine deoxynucleosides tested displayed comparable DNA-damaging potency but did not affect mitochondrial function. Interference with mitochondrial integrity, thus, may be a factor in the potent cytotoxic effects of 2CdA and CaFdA toward nondividing lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11071652

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

1.  Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.

Authors:  Koen van Besien; Wendy Stock; Elizabeth Rich; Olatoyosi Odenike; Lucy A Godley; Peter H O'Donnell; Justin Kline; Vu Nguyen; Paula Del Cerro; Richard A Larson; Andrew S Artz
Journal:  Biol Blood Marrow Transplant       Date:  2011-11-09       Impact factor: 5.742

2.  Clofarabine: in pediatric patients with acute lymphoblastic leukemia.

Authors:  Monique P Curran; Caroline M Perry
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

3.  Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study.

Authors:  Yogesh T Patel; Megan O Jacus; Nidal Boulos; Jason D Dapper; Abigail D Davis; Pradeep K Vuppala; Burgess B Freeman; Kumarasamypet M Mohankumar; Stacy L Throm; Richard J Gilbertson; Clinton F Stewart
Journal:  Cancer Chemother Pharmacol       Date:  2015-02-28       Impact factor: 3.333

4.  Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATP.

Authors:  Kumudha Balakrishnan; Christine M Stellrecht; Davide Genini; Mary Ayres; William G Wierda; Michael J Keating; Lorenzo M Leoni; Varsha Gandhi
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

Review 5.  Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies.

Authors:  Tadeusz Robak
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

6.  NO Photoreleaser-Deoxyadenosine and -Bile Acid Derivative Bioconjugates as Novel Potential Photochemotherapeutics.

Authors:  Maria Luisa Navacchia; Aurore Fraix; Nicola Chinaglia; Eleonora Gallerani; Daniela Perrone; Venera Cardile; Adriana C E Graziano; Massimo L Capobianco; Salvatore Sortino
Journal:  ACS Med Chem Lett       Date:  2016-08-18       Impact factor: 4.345

7.  Haploidentical Donor Transplantation Using a Novel Clofarabine-containing Conditioning Regimen for Very High-risk Hematologic Malignant Neoplasms.

Authors:  Akshay Sharma; Guolian Kang; Anusha Sunkara; Hiroto Inaba; Sima Jeha; Shane J Cross; Terrence Geiger; Brandon Triplett
Journal:  J Pediatr Hematol Oncol       Date:  2018-11       Impact factor: 1.289

8.  Promotion of Caspase Activation by Caspase-9-mediated Feedback Amplification of Mitochondrial Damage.

Authors:  Alan D Guerrero; Ingo Schmitz; Min Chen; Jin Wang
Journal:  J Clin Cell Immunol       Date:  2012-08-09

9.  Use of clofarabine for acute childhood leukemia.

Authors:  A Pession; R Masetti; K Kleinschmidt; A Martoni
Journal:  Biologics       Date:  2010-06-24

10.  Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia.

Authors:  Etienne Moussay; Valérie Palissot; Laurent Vallar; Hélène A Poirel; Thomas Wenner; Victoria El Khoury; Nasséra Aouali; Kris Van Moer; Bernadette Leners; François Bernardin; Arnaud Muller; Pascale Cornillet-Lefebvre; Alain Delmer; Caroline Duhem; Fernand Ries; Eric van Dyck; Guy Berchem
Journal:  Mol Cancer       Date:  2010-05-20       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.